Blog Examines Debate Surrounding High Cost Of Hepatitis C Drug

The Center for Global Health Policy’s “Science Speaks” blog summarizes ongoing debate surrounding the high cost of a newly approved and highly effective treatment for Hepatitis C. “…[T]he drug shortens treatment for chronic hepatitis C from 48 weeks to 12, and offers a 90 percent cure rate, at more than $80,000 for a course of treatment,” the blog notes (Barton, 2/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.